JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilk, S.
Right arrow Articles by Orlowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilk, S.
Right arrow Articles by Orlowski, M.

gamma-Glutamyl dopa: a kidney-specific dopamine precursor

S Wilk, H Mizoguchi and M Orlowski

gamma-Glutamyl derivatives of amino acids and peptides are selectively accumulated in the kidney and introduced into the metabolism of kidney cells. gamma-Glutamyl L-3,4-dihydroxyphenylalanine (gamma-glutamyl dopa) was synthesized both chemically and enzymatically. Injection of this derivative into mice led to a selective generation of dopamine in the kidney as a consequence of the sequential action of gamma-glutamyl transpeptidase and aromatic L-amino acid decarboxylase, two enzymes which are highly concentrated in the kidney. The concentration of dopamine in the kidney after gamma-glutamyl dopa was almost 5 times higher than that after an equivalent dose of L-dopa. Infusion of 10 nmol/g/30 min of gamma-glutamyl dopa to rats produced a 60% increase in renal plasma flow. By contrast the same dose of L-dopa had no effect on renal plasma flow. Only a small pressor effect was observed after the infusion dose of gamma-glutamyl dopa was increased 20-fold indicating that the systemic effects of this pro-drug slight. The results suggest that the pro-drug gamma-glutamyl dopa can be used as a specific renal vasodilator.

Volume 206, Issue 1, pp. 227-232, 07/01/1978
Copyright © 1978 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 HypertensionHome page
R. M. Carey
Renal Dopamine System: Paracrine Regulator of Sodium Homeostasis and Blood Pressure
Hypertension, September 1, 2001; 38(3): 297 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Brismar, M. Asghar, R. M. Carey, P. Greengard, and A. Aperia
Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane
PNAS, May 12, 1998; 95(10): 5573 - 5578.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. W. Lohr, G. R. Willsky, and M. A. Acara
Renal Drug Metabolism
Pharmacol. Rev., March 1, 1998; 50(1): 107 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. H. Lin and A. Y. H. Lu
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Pharmacol. Rev., December 1, 1997; 49(4): 403 - 449.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Z.-Q. Wang, H. M. Siragy, R. A. Felder, and R. M. Carey
Intrarenal Dopamine Production and Distribution in the Rat: Physiological Control of Sodium Excretion
Hypertension, January 1, 1997; 29(1): 228 - 234.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics.